| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | James A Wells | |
| Daniel A Erlanson | |||
| Andrew C Braisted | |||
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 199-223 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Annual Review of Biophysics and Biomolecular Structure | Q26853798 |
| P1476 | title | Tethering: fragment-based drug discovery | |
| P478 | volume | 33 |
| Q44528059 | A century at the chemistry-biology interface |
| Q34595353 | A common allosteric site and mechanism in caspases |
| Q36732253 | A decade of fragment-based drug design: strategic advances and lessons learned |
| Q31145317 | A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design |
| Q35175346 | A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases |
| Q27684920 | A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand |
| Q34541773 | A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases |
| Q33924947 | A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action |
| Q33547251 | A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH. |
| Q27664106 | A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules |
| Q24644915 | A tethering mechanism for length control in a processive carbohydrate polymerization |
| Q28287639 | Advances in Bioconjugation |
| Q35848043 | Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery |
| Q36884733 | Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface |
| Q27680467 | Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus |
| Q30370820 | Allosteric regulation and catalysis emerge via a common route. |
| Q33601580 | Allosteric regulation of protease activity by small molecules. |
| Q36083038 | An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor. |
| Q56395829 | An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering |
| Q98771871 | Application of Fragment-Based Drug Discovery to Versatile Targets |
| Q46774673 | Challenges facing the biologist doing chemical genetics |
| Q36685852 | Chemical crosshairs on the central dogma |
| Q57307431 | Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs |
| Q34598558 | Combined mass spectrometry and dynamic chemistry approach to identify metalloenzyme inhibitors |
| Q27650049 | Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase |
| Q38364115 | Computer applications for prediction of protein-protein interactions and rational drug design. |
| Q42225889 | Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy |
| Q37401733 | Conduits of life's spark: a perspective on ion channel research since the birth of neuron |
| Q57751804 | Conservation of coactivator engagement mechanism enables small-molecule allosteric modulators |
| Q36072400 | Covalent Tethering of Fragments For Covalent Probe Discovery |
| Q37394041 | Covalent capture: merging covalent and noncovalent synthesis |
| Q33710476 | Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy |
| Q34414451 | Covalent small molecule inhibitors of Ca(2+)-bound S100B. |
| Q33515335 | Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds |
| Q88815851 | Cryptic binding sites on proteins: definition, detection, and druggability |
| Q79314147 | Deconstructing fragment-based inhibitor discovery |
| Q29038357 | Dependence of Effective Molarity on Linker Length for an Intramolecular Protein−Ligand System |
| Q33417723 | Design of compound libraries for fragment screening |
| Q58837454 | Developing Small-Molecule Inhibitors of HECT-Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities |
| Q26784027 | Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction Networks |
| Q40523781 | Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods |
| Q30831384 | Discovery of an allosteric site in the caspases |
| Q33211921 | Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor |
| Q28553211 | Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2) |
| Q34464112 | Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets. |
| Q34389280 | Dynamic combinatorial/covalent chemistry: a tool to read, generate and modulate the bioactivity of compounds and compound mixtures |
| Q37579402 | Dynamic template-assisted strategies in fragment-based drug discovery. |
| Q46276303 | Engineering peptide ligase specificity by proteomic identification of ligation sites. |
| Q35009555 | Evolutions in fragment-based drug design: the deconstruction-reconstruction approach |
| Q27936541 | Exploitation of latent allostery enables the evolution of new modes of MAP kinase regulation |
| Q53834774 | Exploring the structural origins of cryptic sites on proteins. |
| Q90257936 | Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation |
| Q39085729 | FP Tethering: a screening technique to rapidly identify compounds that disrupt protein-protein interactions |
| Q26996645 | Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity |
| Q33325589 | Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners |
| Q90299052 | Fragment Pose Prediction Using Non-equilibrium Candidate Monte Carlo and Molecular Dynamics Simulations |
| Q27676351 | Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes |
| Q37995087 | Fragment informatics and computational fragment-based drug design: an overview and update |
| Q26826945 | Fragment screening and HIV therapeutics |
| Q27676592 | Fragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray Crystallography |
| Q34345451 | Fragment-based drug discovery using NMR spectroscopy |
| Q28262032 | Fragment-based lead discovery: leads by design |
| Q38211688 | Harnessing allostery: a novel approach to drug discovery |
| Q52685551 | High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery. |
| Q41955342 | Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR. |
| Q27674057 | Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction |
| Q40836289 | Identification of specific tethered inhibitors for caspase-5. |
| Q92443122 | Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead |
| Q47750102 | Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA-Encoded Self-Assembling Chemical Libraries. |
| Q27655287 | Impact of linker strain and flexibility in the design of a fragment-based inhibitor |
| Q38029118 | In silico fragment-based drug design |
| Q34626302 | In situ click chemistry: a powerful means for lead discovery |
| Q58488710 | In vitro selection of a peptide aptamer that potentiates inhibition of cyclin-dependent kinase 2 by purvalanol |
| Q36731111 | Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases |
| Q46691166 | Inhibition of the calcineurin-NFAT interaction by small organic molecules reflects binding at an allosteric site |
| Q28656132 | Inhibitor of MYC identified in a Kröhnke pyridine library |
| Q87406316 | Kinetic template-guided tethering of fragments |
| Q35616254 | Ligand deconstruction: Why some fragment binding positions are conserved and others are not |
| Q36677212 | Ligand-based vascular targeting of disease |
| Q27664411 | Loop-Swapped Chimeras of the Agouti-Related Protein and the Agouti Signaling Protein Identify Contacts Required for Melanocortin 1 Receptor Selectivity and Antagonism |
| Q51239957 | Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation. |
| Q33261442 | Mimicking damaged DNA with a small molecule inhibitor of human UNG2. |
| Q27649995 | Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors |
| Q60458527 | Modulating the masters: chemical tools to dissect CBP and p300 function |
| Q43232912 | Molecular basis of cytokine signalling--theme and variations |
| Q28079554 | Motif mediated protein-protein interactions as drug targets |
| Q37149486 | Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin- dependent N-end rule pathway |
| Q48166476 | NMR-Fragment Based Virtual Screening: A Brief Overview |
| Q28298611 | Navigating chemical space for biology and medicine |
| Q47214042 | Novel K-Ras G12C Switch-II covalent binders destabilize Ras and accelerate nucleotide exchange |
| Q36723089 | On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry |
| Q38195457 | Oncogenic protein interfaces: small molecules, big challenges. |
| Q34930997 | Perspectives on NMR in drug discovery: a technique comes of age |
| Q34522767 | Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions |
| Q38199945 | Probing secondary interactions in biomolecular recognition by dynamic combinatorial chemistry |
| Q42284251 | Profiling the dynamic interfaces of fluorinated transcription complexes for ligand discovery and characterization |
| Q42747306 | Protein binding: Antibody surrogates click into place |
| Q26738763 | Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery |
| Q46403752 | Quantifying Escherichia coli glutaredoxin-3 substrate specificity using ligand-induced stability |
| Q33259490 | Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking |
| Q91796904 | Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening |
| Q33432440 | Rapid identification of improved protein ligands using peptoid microarrays |
| Q46107918 | Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States |
| Q47687205 | Reduced dimensionality (4,3)D-hnCOCANH experiment: an efficient backbone assignment tool for NMR studies of proteins |
| Q33530277 | Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries |
| Q33230098 | Selective delivery of therapeutic agents for the diagnosis and treatment of cancer |
| Q42645907 | Selective, rapid and optically switchable regulation of protein function in live mammalian cells. |
| Q80891407 | Sensitized detection of inhibitory fragments and iterative development of non-peptidic protease inhibitors by dynamic ligation screening |
| Q48913104 | Silent, fluorescent labeling of native neuronal receptors |
| Q45154618 | Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor |
| Q26785992 | Small Molecule Targeting of Protein-Protein Interactions through Allosteric Modulation of Dynamics |
| Q34311126 | Small molecule ion channel match making: a natural fit for new ASIC ligands. |
| Q34263719 | Small-molecule inhibitors of protein-protein interactions: progressing toward the reality |
| Q36908318 | Solid-phase glycan isolation for glycomics analysis |
| Q42675145 | Some Trends in Chem(o)informatics |
| Q40144153 | Specific modulation of protein activity by using a bioorthogonal reaction |
| Q35738960 | State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors |
| Q30992306 | Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis |
| Q42411842 | Structural analysis of caspase-1 inhibitors derived from Tethering. |
| Q27649211 | Structural genomics of protein phosphatases |
| Q38784214 | Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate |
| Q56970008 | Structure-Based Drug Discovery Without Structure: Working Around the Paradox to Disrupt Protein-Protein Associations |
| Q35654150 | Structure-based redesign of an edema toxin inhibitor |
| Q90170351 | Tailored therapeutics based on 1,2,3-1H-triazoles: a mini review |
| Q34347892 | Targeting protein-protein interactions as an anticancer strategy |
| Q33935824 | Temperature-sensitive protein-DNA dimerizers |
| Q34520855 | The GABA(A) receptor as a target for photochromic molecules |
| Q60921637 | The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1 |
| Q34274356 | The impact of click chemistry in medicinal chemistry |
| Q28472769 | The overlap of small molecule and protein binding sites within families of protein structures |
| Q26995817 | The pharmacological landscape and therapeutic potential of serine hydrolases |
| Q54484266 | The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode. |
| Q34373258 | Therapeutic Targeting of Myc. |
| Q27667313 | Turning a protein kinase on or off from a single allosteric site via disulfide trapping |
| Q36494279 | Unique MAP Kinase binding sites |
| Q64327308 | Using Fragment-Based Approaches to Discover New Antibiotics |
| Q91666995 | Vinyl sulfonamide synthesis for irreversible tethering via a novel α-selenoether protection strategy |
| Q30864246 | Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide |
| Q34368348 | Virtual fragment screening: exploration of MM-PBSA re-scoring |
Search more.